Shingles Vaccine Linked to Lower Dementia Risk

By Longevity Lab · Published: July 30, 2026

Based on peer-reviewed research — full source list at the end of this article. This is educational information, not medical advice.

Adults who got the shingles vaccine were about 20% less likely to receive a new dementia diagnosis over roughly 7 years, according to a large natural experiment in Wales published in Nature in 2025. The finding matters as much for how it was obtained as for what it shows: the study design comes closer to randomization than almost any other analysis of vaccines and brain health.

What the natural experiment was

When Wales rolled out its shingles vaccination program, free vaccination was offered to people born on or after a specific date, while people born a few days earlier were not eligible. The two groups are almost identical in age, and the only real difference between them is access to the vaccine. That creates a situation close to random assignment: by comparing nearly identical groups just below and just above the birth-date cutoff, researchers can estimate the effect of the vaccine itself rather than the lifestyle of people who choose to be vaccinated. This is why such a design is valued far above a standard observational study.

What the study found about the shingles vaccine and dementia

The results, published in the journal Nature, were substantial:

• people who received the vaccine were several percentage points less likely to receive a new dementia diagnosis over roughly 7 years, which corresponds to a relative risk reduction on the order of 20%;
• the effect was stronger in women;
• the association held after accounting for many other factors, and it was supported by the rigor of the study design.

Why a shingles vaccine might affect the brain

Shingles is caused by the varicella-zoster virus, the same virus behind childhood chickenpox. After that first infection it stays dormant for life in nerve ganglia and can reactivate in older age. One hypothesis is that these reactivations, and the inflammation that comes with them, contribute to dementia through chronic Neuroinflammation. If so, a vaccine that reduces reactivation would indirectly protect the brain. Researchers also discuss a broader effect of the vaccine on the immune system. But the exact mechanism is not established, and this study does not prove one: it documents an association, not a cause.

Does the shingles vaccine protect against dementia?

The finding needs careful interpretation:

• this is strong evidence, but it is still not a randomized clinical trial. It is a quasi-experiment;
• the result comes from one specific (live) vaccine and one specific population;
• the vaccine does not treat dementia that has already developed, and it guarantees protection to no one;
• the shingles vaccine already has a well-established main benefit: it prevents shingles, which is painful and carries dangerous complications in older adults.

In other words, possible protection of the brain is a welcome potential bonus on top of the reason the vaccine is given in the first place. Discuss vaccination with your doctor in the context of your age and your indications, not as a dementia treatment.

Viruses and the brain: why researchers are paying attention

The finding fits a growing interest in the role of infections and immunity in dementia. For years the amyloid hypothesis of Alzheimer’s disease dominated the field, but amyloid alone turned out not to explain enough, and scientists are looking more closely at chronic inflammation and dormant viral infections as possible contributors. Infection is only one strand of a much larger picture, which we unpack in our overview of Cognitive aging: the brain, memory, and dementia risk.

Varicella-zoster is not the only suspect; other herpesviruses are under discussion too. The logic is that dormant infections can reactivate periodically as immunity weakens with age, sustaining inflammation in nervous tissue. If that is right, anything that reduces the frequency of reactivation, including vaccines, could in principle protect the brain. For now that remains a hypothesis, not an established fact.

Why the conclusion is still treated with caution:

• it is a quasi-experiment, not a randomized clinical trial;
• the protective mechanism has not been proven;
• part of the effect may reflect the characteristics of people who choose to be vaccinated;
• direct clinical trials are needed before anyone can speak about causation.

What to do now

The practical takeaway from this news is modest and sensible. The shingles vaccine is already recommended for many older adults, primarily to avoid shingles itself, which can be extremely painful and carries serious complications. A possible benefit for the brain is an extra argument in favor of vaccination, not a reason on its own. Whichever way that conversation goes, it helps to know where your own thinking stands today, which is the point of our short self-assessment Cognitive age: is your brain older than you?

For brain health overall, the most reliable levers are the well-tested ones: physical activity, blood pressure and blood sugar control, sleep, not smoking, and mental and social engagement, which builds Cognitive reserve. Those, rather than any single vaccine, are the foundation of dementia prevention. Blood pressure is usually the fastest of them to act on, so it is worth checking which of the standard Blood pressure categories your own readings fall into.

What actually lowers dementia risk according to the evidence:

• regular physical activity;
• control of cardiovascular risk factors (blood pressure, glucose, lipids);
• enough sleep;
• not smoking;
• social and cognitive engagement.

Frequently asked questions

Source: Eyting M, et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641:438–446. PubMed →

Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.